Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2007-09-25
2007-09-25
Ramirez, Delia M. (Department: 1652)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S320100, C435S069100, C435S015000, C435S252300, C435S193000, C536S023100, C536S023200, C536S023500, C530S350000
Reexamination Certificate
active
10661049
ABSTRACT:
Core 1 β3-galactosyl transferase specific molecular chaperones (Cosmc-1) and nucleic acids encoding the core 1 β3-galactosyl transferase specific molecular chaperones or proteins having core 1 β3-galactosyl transferase specific molecular chaperone activity are described. The polynucleotides encoding Cosmc-1 can be used to transform or transfect host cells for producing substantially pure forms of active forms of core 1 β3-galactosyl transferase and/or for use in an expression system for post-translational core 1 glycosylation of proteins or peptides produced within the expression system, for example, glycosylation via a β3-linkage, of an N-acetylgalactosamine linked to a serine, threonine or other linking amino acid on peptides or proteins requiring O-, N-, or S-linked glycosylation.
REFERENCES:
patent: 6492152 (2002-12-01), Canfield et al.
patent: 6635468 (2003-10-01), Ashkenazi et al.
patent: WO 00/15796 (2000-03-01), None
patent: WO 2001/40466 (2001-06-01), None
Branden et al., Introduction to Protein Structure, Garland Publishing Inc., New York, p. 247, 1991.
Witkowski et al., Biochemistry 38:11643-11650, 1999.
Seffernick et al., J. Bacteriol. 183(8):2405-2410, 2001.
Kappel et al., Current Opinion in Biotechnology 3:548-553, 1992.
Mullins et al., Hypertension 22(4):630-633, 1993.
Mullins et al., J. Clin. Invest. 97(7):1557-1560, 1996.
Wigley et al., Reprod. Fert. Dev. 6:585-588, 1994.
Cameron, E., Molecular Biotechnology 7:253-265, 1997.
Philips, A., J. Pharm. Pharmacology 53:1169-1174, 2001.
Gardlik et al., Med. Sci. Monit. 11(4):RA110-121, 2005.
Current Protocols in Molecular Biology, Hybridization Analysis of DNA Blots, pp. 2.10.8-2.10.11, 1993.
Berger, E. G., “Tn-syndrome”,Biochim Biophys Acta1455, (1999) 255-268.
Brockhausen, I., et al., “Enzymatic basis for sialyl-Tn expression in human colon cancer cells”,Clycoconj J15, (1998) 595-603.
Ju, T., et al., “Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase”,J Biol Chem277, (2002) 178-186.
Ju, T., et al., “Purification, Characterization, and Subunit Structure of Rat Core 1 β1,3-Galactosyltransferase”,J Biol Chem277, (2002) 169-177.
McEver, R. P., et al., “Perspectives Series: Cell Adhesion in Vascular Biology”,J. Clin Invest100, (1997) 485-491.
Novak, J., et al., “Progress in Molecular and Genetic Studies of IgA Nephropathy”,J Clin Immunol21, (2001) 310-327.
Piller, V., et al., “Biosynthesis of Truncated O-Glycans in the T Cell Line Jurkat”,J Biol Chem265, (1990) 9264-9271.
Springer, G. F., “Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy”,J Mol Med75, (1997) 594-602.
Wells, L., et al., “Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins”,J Biol Chem277, (2002) 1755-1761.
Cummings Richard D.
Ju Tongzhong
Dunlap Codding & Rogers P.C.
Ramirez Delia M.
The Board of Regents of the University of Oklahoma
LandOfFree
Core 1 β3-galactosyltransferase specific molecular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Core 1 β3-galactosyltransferase specific molecular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Core 1 β3-galactosyltransferase specific molecular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3766030